Cargando…

Structure of sulfamidase provides insight into the molecular pathology of mucopolysaccharidosis IIIA

Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome), a fatal childhood-onset neurodegenerative disease with mild facial, visceral and skeletal abnormalities, is caused by an inherited deficiency of the enzyme N-sulfoglucosamine sulfohydrolase (SGSH; sulfamidase). More than 100 mutations in the S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sidhu, Navdeep S., Schreiber, Kathrin, Pröpper, Kevin, Becker, Stefan, Usón, Isabel, Sheldrick, George M., Gärtner, Jutta, Krätzner, Ralph, Steinfeld, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Union of Crystallography 2014
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014121/ https://www.ncbi.nlm.nih.gov/pubmed/24816101 http://dx.doi.org/10.1107/S1399004714002739

Ejemplares similares

Enhancing the Therapeutic Potential of Sulfamidase for the Treatment of Mucopolysaccharidosis IIIA
por: Sorrentino, Nicolina Cristina, et al.
Publicado: (2019)

Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene Therapy
por: Chen, Yonghong, et al.
Publicado: (2018)

Intravenous delivery of a chemically modified sulfamidase efficiently reduces heparan sulfate storage and brain pathology in mucopolysaccharidosis IIIA mice
por: Gustavsson, Susanne, et al.
Publicado: (2019)

Structure and activity of the only human RNase T2
por: Thorn, Andrea, et al.
Publicado: (2012)

From hypertransaminasemia to mucopolysaccharidosis IIIA
por: Krawiec, Paulina, et al.
Publicado: (2014)

Prediction of phenotypic severity in mucopolysaccharidosis type IIIA
por: Knottnerus, Suzan J. G., et al.
Publicado: (2017)

Bioinformatics classification of mutations in patients with Mucopolysaccharidosis IIIA
por: Tanwar, Himani, et al.
Publicado: (2019)

Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA
por: Bugiani, Marianna, et al.
Publicado: (2023)

Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA
por: Anson, Donald S, et al.
Publicado: (2007)

Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB
por: Wilkinson, Fiona L., et al.
Publicado: (2012)

Distribution of Heparan Sulfate Oligosaccharides in Murine Mucopolysaccharidosis Type IIIA
por: Mason, Kerryn, et al.
Publicado: (2014)

Neurocognitive testing in a murine model of mucopolysaccharidosis type IIIA
por: Pericleous, Kleopatra, et al.
Publicado: (2023)

An immune deficient mouse model for mucopolysaccharidosis IIIA (Sanfilippo syndrome)
por: Pollock, Kari, et al.
Publicado: (2023)

Structure solution of DNA-binding proteins and complexes with ARCIMBOLDO libraries
por: Pröpper, Kevin, et al.
Publicado: (2014)

Cln5 represents a new type of cysteine-based S-depalmitoylase linked to neurodegeneration
por: Luebben, Anna V., et al.
Publicado: (2022)

Cardiac disease as the presenting feature of mucopolysaccharidosis type IIIA: A case report
por: Ribeiro, Erlane Marques, et al.
Publicado: (2014)

A novel mutation of SGSH and clinical features analysis of mucopolysaccharidosis type IIIA
por: Li, Xiaohua, et al.
Publicado: (2018)

LC-MS Based Platform Simplifies Access to Metabolomics for Peroxisomal Disorders
por: Klemp, Henry Gerd, et al.
Publicado: (2021)

Increased Alveolar Heparan Sulphate and Reduced Pulmonary Surfactant Amount and Function in the Mucopolysaccharidosis IIIA Mouse
por: Paget, Tamara L., et al.
Publicado: (2021)

Female Mucopolysaccharidosis IIIA Mice Exhibit Hyperactivity and a Reduced Sense of Danger in the Open Field Test
por: Langford-Smith, Alex, et al.
Publicado: (2011)

A Multiparametric Computational Algorithm for Comprehensive Assessment of Genetic Mutations in Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome)
por: Ugrinov, Krastyu G., et al.
Publicado: (2015)

Haematopoietic stem cell gene therapy with IL‐1Ra rescues cognitive loss in mucopolysaccharidosis IIIA
por: Parker, Helen, et al.
Publicado: (2020)

Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene Replacement Vector
por: Bobo, Tierra A., et al.
Publicado: (2020)

Intracerebroventricular dosing of N-sulfoglucosamine sulfohydrolase in mucopolysaccharidosis IIIA mice reduces markers of brain lysosomal dysfunction
por: Magat, Jenna, et al.
Publicado: (2022)

An introduction to experimental phasing of macromolecules illustrated by SHELX; new autotracing features
por: Usón, Isabel, et al.
Publicado: (2018)

Impact of chemical modification of sulfamidase on distribution to brain interstitial fluid and to CSF after an intravenous administration in awake, freely-moving rats
por: Janson, Juliette, et al.
Publicado: (2019)

Hip pathologies in mucopolysaccharidosis type III
por: Breyer, Sandra Rafaela, et al.
Publicado: (2021)

Insulin Receptor Antibody–Sulfamidase Fusion Protein Penetrates the Primate Blood–Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type A Cells
por: Boado, Ruben J., et al.
Publicado: (2014)

Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated Ex Vivo Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIA
por: Ellison, Stuart M., et al.
Publicado: (2019)

Hematopoietic stem cell transplantation in mucopolysaccharidosis type IIIA: A case description and comparison with a genotype-matched control group
por: Köhn, Anja F., et al.
Publicado: (2020)

Arterial Pathology in Canine Mucopolysaccharidosis-I and Response to Therapy
por: Lyons, Jeremiah A., et al.
Publicado: (2011)

Practical structure solution with ARCIMBOLDO
por: Rodríguez, Dayté, et al.
Publicado: (2012)

Molecular architecture with carbohydrate functionalized β-peptides adopting 3(14)-helical conformation
por: Pawar, Nitin J, et al.
Publicado: (2014)

Non-merohedral twinning: from minerals to proteins
por: Sevvana, Madhumati, et al.
Publicado: (2019)

Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology
por: Hampe, Christiane S., et al.
Publicado: (2020)

Disease pathology signatures in a mouse model of Mucopolysaccharidosis type IIIB
por: Petrova, Ralitsa, et al.
Publicado: (2023)

Mucopolysaccharidosis VI
por: Valayannopoulos, Vassili, et al.
Publicado: (2010)

Ionic liquids IIIA
por: Rogers, Robin D, et al.
Publicado: (2005)

Airway Abnormalities in Adult Mucopolysaccharidosis and Development of Salford Mucopolysaccharidosis Airway Score
por: Gadepalli, Chaitanya, et al.
Publicado: (2021)

Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT
por: Pan, Xuefang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oq5gk7vurut9ijf69bpglti6ag